APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Zoster Vaccine Live

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Zoster Vaccine Live Market Outlook and Growth Opportunities 2026

Report ID 174048960419 December 2025196 pages

Choose your research edition.

Industry ResearchZoster Vaccine Live Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Zoster Vaccine Live Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Zoster Vaccine Live Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zoster Vaccine Live Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Zoster Vaccine Live Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Zoster Vaccine Live market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Zoster Vaccine Live market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Zoster Vaccine Live market include Merck and GSK among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Zoster Vaccine Live market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Zoster Vaccine Live and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zoster Vaccine Live sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Zoster Vaccine Live market size, projected growth trends, production technologies, key applications, and end-use industries.

Zoster Vaccine Live Segment by Company

Merck

GSK

Zoster Vaccine Live Segment by Type

Monovalent Vaccine

Combination Vaccine

Zoster Vaccine Live Segment by Application

Kids Injection

Adults Injection

Zoster Vaccine Live Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Zoster Vaccine Live status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Zoster Vaccine Live market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Zoster Vaccine Live significant trends, drivers, influence factors in global and regions.

6. To analyze Zoster Vaccine Live competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zoster Vaccine Live market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zoster Vaccine Live and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zoster Vaccine Live.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zoster Vaccine Live market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Zoster Vaccine Live industry.

Chapter 3: Detailed analysis of Zoster Vaccine Live manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Zoster Vaccine Live in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Zoster Vaccine Live in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Zoster Vaccine Live Industry Trends Table 2. Zoster Vaccine Live Industry Drivers Table 3. Zoster Vaccine Live Industry Opportunities and Challenges Table 4. Zoster Vaccine Live Industry Restraints Table 5. Global Zoster Vaccine Live Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Zoster Vaccine Live Revenue Share by Company (2021-2026) Table 7. Global Zoster Vaccine Live Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Zoster Vaccine Live Sales Volume Share by Company (2021-2026) Table 9. Global Zoster Vaccine Live Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Zoster Vaccine Live Company Ranking, (2024-2026) & (USD Million) Table 11. Global Zoster Vaccine Live Key Company Manufacturing Base & Headquarters Table 12. Global Zoster Vaccine Live Company, Product Type & Application Table 13. Global Zoster Vaccine Live Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Zoster Vaccine Live by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Monovalent Vaccine Table 18. Significant Companies of Combination Vaccine Table 19. Global Zoster Vaccine Live Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Zoster Vaccine Live Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Zoster Vaccine Live Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Zoster Vaccine Live Sales Volume Share by Type (2021-2026) Table 23. Global Zoster Vaccine Live Sales Volume Share by Type (2027-2032) Table 24. Global Zoster Vaccine Live Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Zoster Vaccine Live Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Zoster Vaccine Live Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Zoster Vaccine Live Sales Value Share by Type (2021-2026) Table 28. Global Zoster Vaccine Live Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Kids Injection Table 30. Significant Companies of Adults Injection Table 31. Global Zoster Vaccine Live Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Zoster Vaccine Live Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Zoster Vaccine Live Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Zoster Vaccine Live Sales Volume Share by Application (2021-2026) Table 35. Global Zoster Vaccine Live Sales Volume Share by Application (2027-2032) Table 36. Global Zoster Vaccine Live Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Zoster Vaccine Live Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Zoster Vaccine Live Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Zoster Vaccine Live Sales Value Share by Application (2021-2026) Table 40. Global Zoster Vaccine Live Sales Value Share by Application (2027-2032) Table 41. Global Zoster Vaccine Live Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Zoster Vaccine Live Sales by Region (2021-2026) & (K Units) Table 43. Global Zoster Vaccine Live Sales Market Share by Region (2021-2026) Table 44. Global Zoster Vaccine Live Sales by Region (2027-2032) & (K Units) Table 45. Global Zoster Vaccine Live Sales Market Share by Region (2027-2032) Table 46. Global Zoster Vaccine Live Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Zoster Vaccine Live Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Zoster Vaccine Live Sales Value Share by Region (2021-2026) Table 49. Global Zoster Vaccine Live Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Zoster Vaccine Live Sales Value Share by Region (2027-2032) Table 51. Global Zoster Vaccine Live Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Zoster Vaccine Live Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Zoster Vaccine Live Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Zoster Vaccine Live Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 56. Global Zoster Vaccine Live Sales Market Share by Country (2021-2026) Table 57. Global Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 58. Global Zoster Vaccine Live Sales Market Share by Country (2027-2032) Table 59. Global Zoster Vaccine Live Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Zoster Vaccine Live Sales Value Market Share by Country (2021-2026) Table 61. Global Zoster Vaccine Live Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Zoster Vaccine Live Sales Value Market Share by Country (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Zoster Vaccine Live Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck Zoster Vaccine Live Product Portfolio Table 67. Merck Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Zoster Vaccine Live Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. GSK Zoster Vaccine Live Product Portfolio Table 72. GSK Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. Zoster Vaccine Live Distributors List Table 76. Zoster Vaccine Live Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Zoster Vaccine Live Product Image Figure 2. Global Zoster Vaccine Live Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zoster Vaccine Live Sales Value (2021-2032) & (US$ Million) Figure 4. Global Zoster Vaccine Live Sales (2021-2032) & (K Units) Figure 5. Global Zoster Vaccine Live Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Zoster Vaccine Live Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Monovalent Vaccine Image Figure 10. Combination Vaccine Image Figure 11. Global Zoster Vaccine Live Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Zoster Vaccine Live Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Zoster Vaccine Live Sales Volume Share by Type (2021-2032) Figure 14. Global Zoster Vaccine Live Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Zoster Vaccine Live Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Zoster Vaccine Live Sales Value Share by Type (2021-2032) Figure 17. Kids Injection Image Figure 18. Adults Injection Image Figure 19. Global Zoster Vaccine Live Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Zoster Vaccine Live Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Zoster Vaccine Live Sales Volume Share by Application (2021-2032) Figure 22. Global Zoster Vaccine Live Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Zoster Vaccine Live Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Zoster Vaccine Live Sales Value Share by Application (2021-2032) Figure 25. Global Zoster Vaccine Live Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Zoster Vaccine Live Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Zoster Vaccine Live Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Zoster Vaccine Live Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Zoster Vaccine Live Sales Value (2021-2032) & (US$ Million) Figure 30. North America Zoster Vaccine Live Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Zoster Vaccine Live Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Zoster Vaccine Live Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Zoster Vaccine Live Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Zoster Vaccine Live Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Zoster Vaccine Live Sales Value (2021-2032) & (US$ Million) Figure 36. South America Zoster Vaccine Live Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Zoster Vaccine Live Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Zoster Vaccine Live Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Zoster Vaccine Live Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Zoster Vaccine Live Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Zoster Vaccine Live Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Merck
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zoster Vaccine Live Sales Value (2021-2032)
  4. 1.2.2 Global Zoster Vaccine Live Sales Volume (2021-2032)
  5. 1.2.3 Global Zoster Vaccine Live Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Zoster Vaccine Live Market Dynamics
  1. 2.1 Zoster Vaccine Live Industry Trends
  2. 2.2 Zoster Vaccine Live Industry Drivers
  3. 2.3 Zoster Vaccine Live Industry Opportunities and Challenges
  4. 2.4 Zoster Vaccine Live Industry Restraints
3 Zoster Vaccine Live Market by Company
  1. 3.1 Global Zoster Vaccine Live Company Revenue Ranking in 2025
  2. 3.2 Global Zoster Vaccine Live Revenue by Company (2021-2026)
  3. 3.3 Global Zoster Vaccine Live Sales Volume by Company (2021-2026)
  4. 3.4 Global Zoster Vaccine Live Average Price by Company (2021-2026)
  5. 3.5 Global Zoster Vaccine Live Company Ranking (2024-2026)
  6. 3.6 Global Zoster Vaccine Live Company Manufacturing Base and Headquarters
  7. 3.7 Global Zoster Vaccine Live Company Product Type and Application
  8. 3.8 Global Zoster Vaccine Live Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Zoster Vaccine Live Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Zoster Vaccine Live Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Zoster Vaccine Live Market by Type
  1. 4.1 Zoster Vaccine Live Type Introduction
  2. 4.1.1 Monovalent Vaccine
  3. 4.1.2 Combination Vaccine
  4. 4.2 Global Zoster Vaccine Live Sales Volume by Type
  5. 4.2.1 Global Zoster Vaccine Live Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zoster Vaccine Live Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Zoster Vaccine Live Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Zoster Vaccine Live Sales Value by Type
  9. 4.3.1 Global Zoster Vaccine Live Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Zoster Vaccine Live Sales Value by Type (2021-2032)
  11. 4.3.3 Global Zoster Vaccine Live Sales Value Share by Type (2021-2032)
5 Zoster Vaccine Live Market by Application
  1. 5.1 Zoster Vaccine Live Application Introduction
  2. 5.1.1 Kids Injection
  3. 5.1.2 Adults Injection
  4. 5.2 Global Zoster Vaccine Live Sales Volume by Application
  5. 5.2.1 Global Zoster Vaccine Live Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Zoster Vaccine Live Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Zoster Vaccine Live Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Zoster Vaccine Live Sales Value by Application
  9. 5.3.1 Global Zoster Vaccine Live Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Zoster Vaccine Live Sales Value by Application (2021-2032)
  11. 5.3.3 Global Zoster Vaccine Live Sales Value Share by Application (2021-2032)
6 Zoster Vaccine Live Regional Sales and Value Analysis
  1. 6.1 Global Zoster Vaccine Live Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zoster Vaccine Live Sales by Region (2021-2032)
  3. 6.2.1 Global Zoster Vaccine Live Sales by Region: 2021-2026
  4. 6.2.2 Global Zoster Vaccine Live Sales by Region (2027-2032)
  5. 6.3 Global Zoster Vaccine Live Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Zoster Vaccine Live Sales Value by Region (2021-2032)
  7. 6.4.1 Global Zoster Vaccine Live Sales Value by Region: 2021-2026
  8. 6.4.2 Global Zoster Vaccine Live Sales Value by Region (2027-2032)
  9. 6.5 Global Zoster Vaccine Live Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Zoster Vaccine Live Sales Value (2021-2032)
  12. 6.6.2 North America Zoster Vaccine Live Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Zoster Vaccine Live Sales Value (2021-2032)
  15. 6.7.2 Europe Zoster Vaccine Live Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Zoster Vaccine Live Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Zoster Vaccine Live Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Zoster Vaccine Live Sales Value (2021-2032)
  21. 6.9.2 South America Zoster Vaccine Live Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Zoster Vaccine Live Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Zoster Vaccine Live Sales Value Share by Country, 2025 VS 2032
7 Zoster Vaccine Live Country-level Sales and Value Analysis
  1. 7.1 Global Zoster Vaccine Live Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Zoster Vaccine Live Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Zoster Vaccine Live Sales by Country (2021-2032)
  4. 7.3.1 Global Zoster Vaccine Live Sales by Country (2021-2026)
  5. 7.3.2 Global Zoster Vaccine Live Sales by Country (2027-2032)
  6. 7.4 Global Zoster Vaccine Live Sales Value by Country (2021-2032)
  7. 7.4.1 Global Zoster Vaccine Live Sales Value by Country (2021-2026)
  8. 7.4.2 Global Zoster Vaccine Live Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Zoster Vaccine Live Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Zoster Vaccine Live Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Zoster Vaccine Live Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Zoster Vaccine Live Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Zoster Vaccine Live Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Zoster Vaccine Live Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GSK Zoster Vaccine Live Product Portfolio
  12. 8.2.5 GSK Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Zoster Vaccine Live Value Chain Analysis
  2. 9.1.1 Zoster Vaccine Live Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Zoster Vaccine Live Sales Mode & Process
  6. 9.2 Zoster Vaccine Live Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Zoster Vaccine Live Distributors
  9. 9.2.3 Zoster Vaccine Live Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst